- Home
- VYGR vs PBFS Comparison
VYGR vs PBFS Comparison
Compare VYGR & PBFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- PBFS
- Stock Information
- Founded
- VYGR 2013
- PBFS 1889
- Country
- VYGR United States
- PBFS United States
- Employees
- VYGR N/A
- PBFS N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- PBFS Banks
- Sector
- VYGR Health Care
- PBFS Finance
- Exchange
- VYGR Nasdaq
- PBFS Nasdaq
- Market Cap
- VYGR 342.5M
- PBFS 289.1M
- IPO Year
- VYGR 2015
- PBFS N/A
- Fundamental
- Price
- VYGR $5.22
- PBFS $11.28
- Analyst Decision
- VYGR Strong Buy
- PBFS
- Analyst Count
- VYGR 9
- PBFS 0
- Target Price
- VYGR $15.53
- PBFS N/A
- AVG Volume (30 Days)
- VYGR 361.6K
- PBFS 17.2K
- Earning Date
- VYGR 02-26-2025
- PBFS 02-05-2025
- Dividend Yield
- VYGR N/A
- PBFS N/A
- EPS Growth
- VYGR N/A
- PBFS N/A
- EPS
- VYGR 0.47
- PBFS 0.72
- Revenue
- VYGR $163,784,000.00
- PBFS $78,364,000.00
- Revenue This Year
- VYGR N/A
- PBFS N/A
- Revenue Next Year
- VYGR N/A
- PBFS N/A
- P/E Ratio
- VYGR $11.19
- PBFS $15.46
- Revenue Growth
- VYGR 3.40
- PBFS N/A
- 52 Week Low
- VYGR $4.99
- PBFS $8.76
- 52 Week High
- VYGR $10.66
- PBFS $12.00
- Technical
- Relative Strength Index (RSI)
- VYGR 38.79
- PBFS 49.07
- Support Level
- VYGR $4.99
- PBFS $11.08
- Resistance Level
- VYGR $5.45
- PBFS $11.26
- Average True Range (ATR)
- VYGR 0.26
- PBFS 0.17
- MACD
- VYGR -0.05
- PBFS 0.01
- Stochastic Oscillator
- VYGR 17.97
- PBFS 56.40
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About PBFS Pioneer Bancorp Inc.
Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.